DANCANN PHARMA A/S
DANCANN PHARMA A/S is a Private limited company (Ltd.) registered in Denmark under 39426005, and its current status with Danish Business Authority — CVR (Central Business Register) is intermediate. The company was incorporated on 20 March 2018 and lists its registered address as Ansager, Denmark. 1 shareholder is on record for DANCANN PHARMA A/S, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last updated on 25 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of DANCANN PHARMA A/S
One shareholder is currently on record for DANCANN PHARMA A/S, filed with Danish Business Authority — CVR (Central Business Register). The largest of these is JEQ Capital AB, holding 10% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| JEQ Capital AB | 10% | Danish Business Authority — CVR (Central Business Register) |
Officers
15
Directors and officers of DANCANN PHARMA A/S
Three of the 15 officer records shown for DANCANN PHARMA A/S are current appointments, filed with Danish Business Authority — CVR (Central Business Register). Jens Markussen (appointed 2021-03-01) serves as Head Of Production; Charlotte Jorgensen (appointed 2022-09-01) serves as Head Of Quality Assurance; John Frellsen serves as Chief Commercial Officer. The remaining 12 records shown (Jeppe Rasmussen, Magnus Ostergaard Dahlmann and 6 others) are former appointments that have since been resigned. Management authority at DANCANN PHARMA A/S sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of DANCANN PHARMA A/S
DANCANN PHARMA A/S has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- OTC Group ApS
Data availability
Those 1 subsidiary spans Denmark jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
DANCANN PHARMA A/S
Denmark
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns DANCANN PHARMA A/S?
One shareholder is currently on record for DANCANN PHARMA A/S, filed with Danish Business Authority — CVR (Central Business Register). The largest of these is JEQ Capital AB, holding 10% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is DANCANN PHARMA A/S's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for DANCANN PHARMA A/S is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does DANCANN PHARMA A/S have on record?
1 shareholder is shown on record for DANCANN PHARMA A/S.
What is DANCANN PHARMA A/S's company registration number?
DANCANN PHARMA A/S's registration number is 39426005, filed with Danish Business Authority — CVR (Central Business Register) in Denmark. Its current status on the register is intermediate.
Is DANCANN PHARMA A/S still an active company?
DANCANN PHARMA A/S's status on Danish Business Authority — CVR (Central Business Register) is listed as intermediate, not currently active.
When was DANCANN PHARMA A/S incorporated?
DANCANN PHARMA A/S was incorporated on 20 March 2018, according to Danish Business Authority — CVR (Central Business Register).
What is DANCANN PHARMA A/S's registered address?
The registered address on file for DANCANN PHARMA A/S is Ansager, Denmark.
Who are the officers/directors of DANCANN PHARMA A/S?
Three of the 15 officer records shown for DANCANN PHARMA A/S are current appointments, filed with Danish Business Authority — CVR (Central Business Register). Jens Markussen (appointed 2021-03-01) serves as Head Of Production; Charlotte Jorgensen (appointed 2022-09-01) serves as Head Of Quality Assurance; John Frellsen serves as Chief Commercial Officer. The remaining 12 records shown (Jeppe Rasmussen, Magnus Ostergaard Dahlmann and 6 others) are former appointments that have since been resigned. Management authority at DANCANN PHARMA A/S sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does DANCANN PHARMA A/S have a parent company or subsidiaries?
DANCANN PHARMA A/S has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans Denmark jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to DANCANN PHARMA A/S's ownership over time?
This profile reflects a point-in-time snapshot from Danish Business Authority — CVR (Central Business Register). Zavia's monitoring API can track changes to DANCANN PHARMA A/S's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access DANCANN PHARMA A/S's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Denmark, so records like DANCANN PHARMA A/S's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last synced on 25 September 2026.